Antoni Ribas
ONCOLOGY
Professor of Medicine at the David Geffen School of Medicine at UCLA; Director of the Tumor Immunology Program at the UCLA Jonsson Comprehensive Cancer Center; Director of the Parker Institute for Cancer Immunotherapy Center at UCLA
UCLA Health
Dr. Antoni Ribas, a world-renowned physician-scientist and pioneer in cancer immunology, has devoted his career to developing and refining new therapies for malignant melanoma. His research focuses on how the immune system can be effectively used to fight cancer in order to develop more effective and less toxic therapies for people with melanoma. He has been recognized by numerous organizations, including the National Academy of Medicine, for defining the mechanistic basis of response and acquired resistance to immune checkpoint blockade cancer immunotherapies, and leading multicenter clinical trials that have provided transformative treatments for patients with advanced melanoma, which was once thought untreatable.
